Suppression of the entire KRAS network by MIR143#12 showed stronger anticancer activity in KRAS mutant colorectal cancer cell lines than suppression of individual genes in the KRAS network, such as KRAS, AKT, and ERK. The gene discussed is MAPK1; the disease is colorectal cancer.